A citation-based method for searching scientific literature

Arb-Aroon Lertkhachonsuk, Prapaporn Suprasert, Tarinee Manchana, Thannaporn Kittisiam, Nuttavut Kantathavorn, Tharintorn Chansoon, Surapan Khunamornpong, Natkrita Pohthipornthawat, Siriwan Tangjitgamol, Taksa Luasiripanthu, Chinachote Teerapakpinyo, Shanop Shuangshot, Nareenart Iemwimangsa, Wasun Chantratita. Asian Pac J Cancer Prev 2020
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
353
100

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer.
Klara Lhotova, Lenka Stolarova, Petra Zemankova, Michal Vocka, Marketa Janatova, Marianna Borecka, Marta Cerna, Sandra Jelinkova, Jan Kral, Zuzana Volkova,[...]. Cancers (Basel) 2020
5
100

Germline mutations in Thai patients with nonmucinous epithelial ovarian cancer.
Tarinee Manchana, Prasit Phowthongkum, Chinachote Teerapakpinyo. World J Clin Oncol 2019
4
100

BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer.
Tingyan Shi, Pan Wang, Caixia Xie, Sheng Yin, Di Shi, Congchong Wei, Wenbin Tang, Rong Jiang, Xi Cheng, Qingyi Wei,[...]. Int J Cancer 2017
27
100

High grade serous ovarian carcinomas originate in the fallopian tube.
S Intidhar Labidi-Galy, Eniko Papp, Dorothy Hallberg, Noushin Niknafs, Vilmos Adleff, Michael Noe, Rohit Bhattacharya, Marian Novak, Siân Jones, Jillian Phallen,[...]. Nat Commun 2017
257
100

New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study.
Inga Plaskocinska, Hannah Shipman, James Drummond, Edward Thompson, Vanessa Buchanan, Barbara Newcombe, Charlotte Hodgkin, Elisa Barter, Paul Ridley, Rita Ng,[...]. J Med Genet 2016
37
100

Germline and somatic mutations of homologous recombination-associated genes in Japanese ovarian cancer patients.
Kentaro Sugino, Ryo Tamura, Hirofumi Nakaoka, Nozomi Yachida, Manako Yamaguchi, Yutaro Mori, Kaoru Yamawaki, Kazuaki Suda, Tatsuya Ishiguro, Sosuke Adachi,[...]. Sci Rep 2019
14
100

Mainstreamed genetic testing for women with ovarian cancer: first-year experience.
Belinda Rahman, Anne Lanceley, Rebecca S Kristeleit, Jonathan A Ledermann, Michelle Lockley, Mary McCormack, Tim Mould, Lucy Side. J Med Genet 2019
26
100

Oncologist-led BRCA 'mainstreaming' in the ovarian cancer clinic: A study of 255 patients and its impact on their management.
Megan Rumford, Mark Lythgoe, Iain McNeish, Hani Gabra, Laura Tookman, Nazneen Rahman, Angela George, Jonathan Krell. Sci Rep 2020
10
100

Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy.
Kasmintan A Schrader, Jane Hurlburt, Steve E Kalloger, Samantha Hansford, Sean Young, David G Huntsman, C Blake Gilks, Jessica N McAlpine. Obstet Gynecol 2012
85
100

Lynch syndrome in the 21st century: clinical perspectives.
A K Tiwari, H K Roy, H T Lynch. QJM 2016
61
100

Germline Mutations of BRCA1 and BRCA2 in Korean Ovarian Cancer Patients: Finding Founder Mutations.
Min Chul Choi, Jin-Hyung Heo, Ja-Hyun Jang, Sang Geun Jung, Hyun Park, Won Duk Joo, Chan Lee, Je Ho Lee, Jun Mo Lee, Yoon Young Hwang,[...]. Int J Gynecol Cancer 2015
23
100

The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications.
Ivo Meinhold-Heerlein, Christina Fotopoulou, Philipp Harter, Christian Kurzeder, Alexander Mustea, Pauline Wimberger, Steffen Hauptmann, Jalid Sehouli. Arch Gynecol Obstet 2016
94
100

Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation.
Joanne Kotsopoulos, Jacek Gronwald, Beth Karlan, Barry Rosen, Tomasz Huzarski, Pal Moller, Henry T Lynch, Christian F Singer, Leigha Senter, Susan L Neuhausen,[...]. Gynecol Oncol 2018
41
100

Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883).
Jan Hauke, Eric Hahnen, Stephanie Schneider, Alexander Reuss, Lisa Richters, Stefan Kommoss, André Heimbach, Frederik Marmé, Sandra Schmidt, Katharina Prieske,[...]. J Med Genet 2019
12
100

Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review.
Marieke Arts-de Jong, Geertruida H de Bock, Christi J van Asperen, Marian J E Mourits, Joanne A de Hullu, C Marleen Kets. Eur J Cancer 2016
39
100

Histotype classification of ovarian carcinoma: A comparison of approaches.
Lauren C Peres, Kara L Cushing-Haugen, Michael Anglesio, Kristine Wicklund, Rex Bentley, Andrew Berchuck, Linda E Kelemen, Tayyebeh M Nazeran, C Blake Gilks, Holly R Harris,[...]. Gynecol Oncol 2018
26
100

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.
J M Piek, P J van Diest, R P Zweemer, J W Jansen, R J Poort-Keesom, F H Menko, J J Gille, A P Jongsma, G Pals, P Kenemans,[...]. J Pathol 2001
475
100

Characteristics of Lynch syndrome associated ovarian cancer.
J M Woolderink, G H De Bock, J A de Hullu, H Hollema, R P Zweemer, B F M Slangen, K N Gaarenstroom, M van Beurden, H C van Doorn, R H Sijmons,[...]. Gynecol Oncol 2018
15
100

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
100

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
63
100

The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients.
Xiaohua Wu, Lingying Wu, Beihua Kong, Jihong Liu, Rutie Yin, Hao Wen, Ning Li, Hualei Bu, Yanling Feng, Qingli Li,[...]. Int J Gynecol Cancer 2017
33
100

The first Japanese nationwide multicenter study of BRCA mutation testing in ovarian cancer: CHARacterizing the cross-sectionaL approach to Ovarian cancer geneTic TEsting of BRCA (CHARLOTTE).
Takayuki Enomoto, Daisuke Aoki, Kana Hattori, Masahisa Jinushi, Junzo Kigawa, Nobuhiro Takeshima, Hitoshi Tsuda, Yoh Watanabe, Kosuke Yoshihara, Toru Sugiyama. Int J Gynecol Cancer 2019
33
100

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
867
100

Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
100

Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.
Pauline Krämer, Aline Talhouk, Mary Anne Brett, Derek S Chiu, Evan S Cairns, Daniëlla A Scheunhage, Rory F L Hammond, David Farnell, Tayyebeh M Nazeran, Marcel Grube,[...]. Clin Cancer Res 2020
17
100

Rare Germline Genetic Variants and the Risks of Epithelial Ovarian Cancer.
Marina Pavanello, Isaac Hy Chan, Amir Ariff, Paul Dp Pharoah, Simon A Gayther, Susan J Ramus. Cancers (Basel) 2020
5
100

Two types of primary mucinous ovarian tumors can be distinguished based on their origin.
Michiel Simons, Femke Simmer, Johan Bulten, Marjolijn J Ligtenberg, Harry Hollema, Shannon van Vliet, Richarda M de Voer, Eveline J Kamping, Dirk F van Essen, Bauke Ylstra,[...]. Mod Pathol 2020
11
100

Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of England.
Nicola Flaum, Robert D Morgan, George J Burghel, Michael Bulman, Andrew R Clamp, Jurjees Hasan, Claire L Mitchell, Doina Badea, Sarah Moon, Martin Hogg,[...]. Eur J Hum Genet 2020
10
100

Pathology of Endometrioid and Clear Cell Carcinoma of the Ovary.
Oluwole Fadare, Vinita Parkash. Surg Pathol Clin 2019
18
100

BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer.
Ikuko Sakamoto, Yosuke Hirotsu, Hiroshi Nakagomi, Hidetaka Ouchi, Atsushi Ikegami, Katsuhiro Teramoto, Kenji Amemiya, Hitoshi Mochizuki, Masao Omata. Cancer 2016
41
100


Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing.
Hsiao-Mei Lu, Shuwei Li, Mary Helen Black, Shela Lee, Robert Hoiness, Sitao Wu, Wenbo Mu, Robert Huether, Jefferey Chen, Srijani Sridhar,[...]. JAMA Oncol 2019
77
100

Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer: a prospective cohort study.
Wenhui Li, Di Shao, Lei Li, Ming Wu, Shuiqing Ma, Xianjie Tan, Sen Zhong, Fengming Guo, Zhe Wang, Mingzhi Ye. J Ovarian Res 2019
12
100

Low-grade serous ovarian carcinoma: A comprehensive literature review.
Elizabeth A Goulding, Bryony Simcock, Jennifer McLachlan, Rachael van der Griend, Peter Sykes. Aust N Z J Obstet Gynaecol 2020
1
100

Routine germline BRCA1 and BRCA2 testing in patients with ovarian carcinoma: analysis of the Scottish real-life experience.
K Rust, P Spiliopoulou, C Y Tang, C Bell, D Stirling, Thf Phang, R Davidson, M Mackean, F Nussey, R M Glasspool,[...]. BJOG 2018
15
100

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
582
100


Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases.
Robert D Morgan, George J Burghel, Nicola Flaum, Michael Bulman, Andrew R Clamp, Jurjees Hasan, Claire L Mitchell, Helene Schlecht, Emma R Woodward, Fiona I Lallo,[...]. J Med Genet 2019
12
100

Outlier and influence diagnostics for meta-analysis.
Wolfgang Viechtbauer, Mike W-L Cheung. Res Synth Methods 2010
490
100

Prevalence of BRCA1 and BRCA2 Mutations in Patients with Primary Ovarian Cancer - Does the German Checklist for Detecting the Risk of Hereditary Breast and Ovarian Cancer Adequately Depict the Need for Consultation?
Beyhan Ataseven, Denise Tripon, Kerstin Rhiem, Philipp Harter, Stephanie Schneider, Florian Heitz, Thais Baert, Alexander Traut, Nina Pauly, Sarah Ehmann,[...]. Geburtshilfe Frauenheilkd 2020
2
100

BRCA mutation frequency and clinical features of ovarian cancer patients: A report from a Chinese study group.
Hualei Bu, Jingying Chen, Qingshui Li, Jianqing Hou, Yuan Wei, Xiaohang Yang, Yana Ma, Hongsheng He, Youzhong Zhang, Beihua Kong. J Obstet Gynaecol Res 2019
4
100

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).
Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuss, Stefan Kommoss, Frederik Marmé, André Heimbach, Katharina Prieske, Lisa Richters, Alexander Burges,[...]. PLoS One 2017
49
100

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition.
Janet R Vos, Ingrid E Fakkert, Joanne A de Hullu, Anne M van Altena, Aisha S Sie, Hicham Ouchene, Riki W Willems, Iris D Nagtegaal, Marjolijn C J Jongmans, Arjen R Mensenkamp,[...]. J Natl Cancer Inst 2020
16
100


Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer.
Akira Hirasawa, Issei Imoto, Takuya Naruto, Tomoko Akahane, Wataru Yamagami, Hiroyuki Nomura, Kiyoshi Masuda, Nobuyuki Susumu, Hitoshi Tsuda, Daisuke Aoki. Oncotarget 2017
21
100

ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer.
R E Miller, A Leary, C L Scott, V Serra, C J Lord, D Bowtell, D K Chang, D W Garsed, J Jonkers, J A Ledermann,[...]. Ann Oncol 2020
45
100

Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.
Diana M Eccles, Judith Balmaña, Joe Clune, Birgit Ehlken, Annegret Gohlke, Ceri Hirst, Danielle Potter, Claudia Schroeder, Jerzy E Tyczynski, Encarnacion B Gomez Garcia. Adv Ther 2016
31
100

Somatic mutations in BRCA1&2 in 201 unselected ovarian carcinoma samples - single institution study.
Artur Kowalik, Kamil Zalewski, Janusz Kopczyński, Monika Siołek, Magda Lech, Kinga Hińcza, Joanna Kalisz, Magdalena Chrapek, Sebastian Zięba, Jowita Furmańczyk,[...]. Pol J Pathol 2019
5
100



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.